Profits before people?: ethical standards and the marketing of prescription drugs
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Bloomington
Indiana University Press
c2006
|
| Schriftenreihe: | Bioethics and the humanities
|
| Schlagworte: | |
| Online-Zugang: | KUBA1 |
| Beschreibung: | Includes bibliographical references (p. [185]-197) and index |
| Beschreibung: | 206 p |
| ISBN: | 0253347483 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV044123052 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 170217s2006 |||| o||u| ||||||eng d | ||
| 020 | |a 0253347483 |c cloth : alk. paper |9 0-253-34748-3 | ||
| 035 | |a (ZDB-30-PAD)EBC288357 | ||
| 035 | |a (ZDB-89-EBL)EBL288357 | ||
| 035 | |a (OCoLC)476041167 | ||
| 035 | |a (DE-599)BVBBV044123052 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-Y3 | ||
| 082 | 0 | |a 174/.96151 |2 22 | |
| 100 | 1 | |a Weber, Leonard J. |d 1942- |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Profits before people? |b ethical standards and the marketing of prescription drugs |c Leonard J. Weber |
| 264 | 1 | |a Bloomington |b Indiana University Press |c c2006 | |
| 300 | |a 206 p | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 490 | 0 | |a Bioethics and the humanities | |
| 500 | |a Includes bibliographical references (p. [185]-197) and index | ||
| 505 | 0 | |a Ethics and for-profit business -- The pharmaceutical industry and its stakeholders -- Drug companies and healthcare professionals : the ethics agenda -- Medical professionalism and scientific integrity -- The industry's code : not good enough -- Drug samples : the most important gifts -- Marketing is not objective education -- Medical education : industry at arm's length -- Clinical research and the limits of commercial interests -- Citizens and consumers -- Direct-to-consumer advertising : conflicting interests -- Direct-to-consumer advertising : better is better | |
| 650 | 4 | |a Ethik | |
| 650 | 4 | |a Pharmaceutical industry |x Moral and ethical aspects |z United States | |
| 650 | 4 | |a Marketing |x Moral and ethical aspects |z United States | |
| 650 | 0 | 7 | |a Wirtschaftsethik |0 (DE-588)4066439-9 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Ethik |0 (DE-588)4015602-3 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Unternehmensethik |0 (DE-588)4202404-3 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Pharmazeutische Industrie |0 (DE-588)4045696-1 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Arzneimittelmarkt |0 (DE-588)4003131-7 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Vermarktung |0 (DE-588)4121857-7 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Arzneimittel |0 (DE-588)4003115-9 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Arzneimittelsicherheit |0 (DE-588)4143182-0 |2 gnd |9 rswk-swf |
| 651 | 4 | |a USA | |
| 651 | 7 | |a USA |0 (DE-588)4078704-7 |2 gnd |9 rswk-swf | |
| 689 | 0 | 0 | |a USA |0 (DE-588)4078704-7 |D g |
| 689 | 0 | 1 | |a Pharmazeutische Industrie |0 (DE-588)4045696-1 |D s |
| 689 | 0 | 2 | |a Arzneimittel |0 (DE-588)4003115-9 |D s |
| 689 | 0 | 3 | |a Vermarktung |0 (DE-588)4121857-7 |D s |
| 689 | 0 | 4 | |a Ethik |0 (DE-588)4015602-3 |D s |
| 689 | 0 | |8 1\p |5 DE-604 | |
| 689 | 1 | 0 | |a USA |0 (DE-588)4078704-7 |D g |
| 689 | 1 | 1 | |a Pharmazeutische Industrie |0 (DE-588)4045696-1 |D s |
| 689 | 1 | 2 | |a Arzneimittelsicherheit |0 (DE-588)4143182-0 |D s |
| 689 | 1 | 3 | |a Unternehmensethik |0 (DE-588)4202404-3 |D s |
| 689 | 1 | |8 2\p |5 DE-604 | |
| 689 | 2 | 0 | |a USA |0 (DE-588)4078704-7 |D g |
| 689 | 2 | 1 | |a Arzneimittelmarkt |0 (DE-588)4003131-7 |D s |
| 689 | 2 | 2 | |a Wirtschaftsethik |0 (DE-588)4066439-9 |D s |
| 689 | 2 | |8 3\p |5 DE-604 | |
| 912 | |a ZDB-30-PAD |a ZDB-30-PBE | ||
| 940 | 1 | |q KUBA1-ZDB-30-PAD-2023 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-029529897 | ||
| 883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 883 | 1 | |8 2\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 883 | 1 | |8 3\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 966 | e | |u https://ebookcentral.proquest.com/lib/khifiit/detail.action?docID=288357 |l KUBA1 |p ZDB-30-PAD |q KHI |x Aggregator |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804177205415116800 |
|---|---|
| any_adam_object | |
| author | Weber, Leonard J. 1942- |
| author_facet | Weber, Leonard J. 1942- |
| author_role | aut |
| author_sort | Weber, Leonard J. 1942- |
| author_variant | l j w lj ljw |
| building | Verbundindex |
| bvnumber | BV044123052 |
| collection | ZDB-30-PAD ZDB-30-PBE |
| contents | Ethics and for-profit business -- The pharmaceutical industry and its stakeholders -- Drug companies and healthcare professionals : the ethics agenda -- Medical professionalism and scientific integrity -- The industry's code : not good enough -- Drug samples : the most important gifts -- Marketing is not objective education -- Medical education : industry at arm's length -- Clinical research and the limits of commercial interests -- Citizens and consumers -- Direct-to-consumer advertising : conflicting interests -- Direct-to-consumer advertising : better is better |
| ctrlnum | (ZDB-30-PAD)EBC288357 (ZDB-89-EBL)EBL288357 (OCoLC)476041167 (DE-599)BVBBV044123052 |
| dewey-full | 174/.96151 |
| dewey-hundreds | 100 - Philosophy & psychology |
| dewey-ones | 174 - Occupational ethics |
| dewey-raw | 174/.96151 |
| dewey-search | 174/.96151 |
| dewey-sort | 3174 596151 |
| dewey-tens | 170 - Ethics (Moral philosophy) |
| discipline | Philosophie |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03564nmm a2200733zc 4500</leader><controlfield tag="001">BV044123052</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">170217s2006 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0253347483</subfield><subfield code="c">cloth : alk. paper</subfield><subfield code="9">0-253-34748-3</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-30-PAD)EBC288357</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-89-EBL)EBL288357</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)476041167</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV044123052</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-Y3</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">174/.96151</subfield><subfield code="2">22</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Weber, Leonard J.</subfield><subfield code="d">1942-</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Profits before people?</subfield><subfield code="b">ethical standards and the marketing of prescription drugs</subfield><subfield code="c">Leonard J. Weber</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Bloomington</subfield><subfield code="b">Indiana University Press</subfield><subfield code="c">c2006</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">206 p</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Bioethics and the humanities</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references (p. [185]-197) and index</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">Ethics and for-profit business -- The pharmaceutical industry and its stakeholders -- Drug companies and healthcare professionals : the ethics agenda -- Medical professionalism and scientific integrity -- The industry's code : not good enough -- Drug samples : the most important gifts -- Marketing is not objective education -- Medical education : industry at arm's length -- Clinical research and the limits of commercial interests -- Citizens and consumers -- Direct-to-consumer advertising : conflicting interests -- Direct-to-consumer advertising : better is better</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Ethik</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical industry</subfield><subfield code="x">Moral and ethical aspects</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Marketing</subfield><subfield code="x">Moral and ethical aspects</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Wirtschaftsethik</subfield><subfield code="0">(DE-588)4066439-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Ethik</subfield><subfield code="0">(DE-588)4015602-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Unternehmensethik</subfield><subfield code="0">(DE-588)4202404-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmazeutische Industrie</subfield><subfield code="0">(DE-588)4045696-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelmarkt</subfield><subfield code="0">(DE-588)4003131-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Vermarktung</subfield><subfield code="0">(DE-588)4121857-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelsicherheit</subfield><subfield code="0">(DE-588)4143182-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="651" ind1=" " ind2="4"><subfield code="a">USA</subfield></datafield><datafield tag="651" ind1=" " ind2="7"><subfield code="a">USA</subfield><subfield code="0">(DE-588)4078704-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">USA</subfield><subfield code="0">(DE-588)4078704-7</subfield><subfield code="D">g</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Pharmazeutische Industrie</subfield><subfield code="0">(DE-588)4045696-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="3"><subfield code="a">Vermarktung</subfield><subfield code="0">(DE-588)4121857-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="4"><subfield code="a">Ethik</subfield><subfield code="0">(DE-588)4015602-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="8">1\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">USA</subfield><subfield code="0">(DE-588)4078704-7</subfield><subfield code="D">g</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Pharmazeutische Industrie</subfield><subfield code="0">(DE-588)4045696-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="2"><subfield code="a">Arzneimittelsicherheit</subfield><subfield code="0">(DE-588)4143182-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="3"><subfield code="a">Unternehmensethik</subfield><subfield code="0">(DE-588)4202404-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="8">2\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="2" ind2="0"><subfield code="a">USA</subfield><subfield code="0">(DE-588)4078704-7</subfield><subfield code="D">g</subfield></datafield><datafield tag="689" ind1="2" ind2="1"><subfield code="a">Arzneimittelmarkt</subfield><subfield code="0">(DE-588)4003131-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="2"><subfield code="a">Wirtschaftsethik</subfield><subfield code="0">(DE-588)4066439-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2=" "><subfield code="8">3\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-30-PAD</subfield><subfield code="a">ZDB-30-PBE</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">KUBA1-ZDB-30-PAD-2023</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-029529897</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">2\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">3\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://ebookcentral.proquest.com/lib/khifiit/detail.action?docID=288357</subfield><subfield code="l">KUBA1</subfield><subfield code="p">ZDB-30-PAD</subfield><subfield code="q">KHI</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| geographic | USA USA (DE-588)4078704-7 gnd |
| geographic_facet | USA |
| id | DE-604.BV044123052 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T07:44:23Z |
| institution | BVB |
| isbn | 0253347483 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-029529897 |
| oclc_num | 476041167 |
| open_access_boolean | |
| owner | DE-Y3 |
| owner_facet | DE-Y3 |
| physical | 206 p |
| psigel | ZDB-30-PAD ZDB-30-PBE KUBA1-ZDB-30-PAD-2023 ZDB-30-PAD KHI |
| publishDate | 2006 |
| publishDateSearch | 2006 |
| publishDateSort | 2006 |
| publisher | Indiana University Press |
| record_format | marc |
| series2 | Bioethics and the humanities |
| spelling | Weber, Leonard J. 1942- Verfasser aut Profits before people? ethical standards and the marketing of prescription drugs Leonard J. Weber Bloomington Indiana University Press c2006 206 p txt rdacontent c rdamedia cr rdacarrier Bioethics and the humanities Includes bibliographical references (p. [185]-197) and index Ethics and for-profit business -- The pharmaceutical industry and its stakeholders -- Drug companies and healthcare professionals : the ethics agenda -- Medical professionalism and scientific integrity -- The industry's code : not good enough -- Drug samples : the most important gifts -- Marketing is not objective education -- Medical education : industry at arm's length -- Clinical research and the limits of commercial interests -- Citizens and consumers -- Direct-to-consumer advertising : conflicting interests -- Direct-to-consumer advertising : better is better Ethik Pharmaceutical industry Moral and ethical aspects United States Marketing Moral and ethical aspects United States Wirtschaftsethik (DE-588)4066439-9 gnd rswk-swf Ethik (DE-588)4015602-3 gnd rswk-swf Unternehmensethik (DE-588)4202404-3 gnd rswk-swf Pharmazeutische Industrie (DE-588)4045696-1 gnd rswk-swf Arzneimittelmarkt (DE-588)4003131-7 gnd rswk-swf Vermarktung (DE-588)4121857-7 gnd rswk-swf Arzneimittel (DE-588)4003115-9 gnd rswk-swf Arzneimittelsicherheit (DE-588)4143182-0 gnd rswk-swf USA USA (DE-588)4078704-7 gnd rswk-swf USA (DE-588)4078704-7 g Pharmazeutische Industrie (DE-588)4045696-1 s Arzneimittel (DE-588)4003115-9 s Vermarktung (DE-588)4121857-7 s Ethik (DE-588)4015602-3 s 1\p DE-604 Arzneimittelsicherheit (DE-588)4143182-0 s Unternehmensethik (DE-588)4202404-3 s 2\p DE-604 Arzneimittelmarkt (DE-588)4003131-7 s Wirtschaftsethik (DE-588)4066439-9 s 3\p DE-604 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 2\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 3\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
| spellingShingle | Weber, Leonard J. 1942- Profits before people? ethical standards and the marketing of prescription drugs Ethics and for-profit business -- The pharmaceutical industry and its stakeholders -- Drug companies and healthcare professionals : the ethics agenda -- Medical professionalism and scientific integrity -- The industry's code : not good enough -- Drug samples : the most important gifts -- Marketing is not objective education -- Medical education : industry at arm's length -- Clinical research and the limits of commercial interests -- Citizens and consumers -- Direct-to-consumer advertising : conflicting interests -- Direct-to-consumer advertising : better is better Ethik Pharmaceutical industry Moral and ethical aspects United States Marketing Moral and ethical aspects United States Wirtschaftsethik (DE-588)4066439-9 gnd Ethik (DE-588)4015602-3 gnd Unternehmensethik (DE-588)4202404-3 gnd Pharmazeutische Industrie (DE-588)4045696-1 gnd Arzneimittelmarkt (DE-588)4003131-7 gnd Vermarktung (DE-588)4121857-7 gnd Arzneimittel (DE-588)4003115-9 gnd Arzneimittelsicherheit (DE-588)4143182-0 gnd |
| subject_GND | (DE-588)4066439-9 (DE-588)4015602-3 (DE-588)4202404-3 (DE-588)4045696-1 (DE-588)4003131-7 (DE-588)4121857-7 (DE-588)4003115-9 (DE-588)4143182-0 (DE-588)4078704-7 |
| title | Profits before people? ethical standards and the marketing of prescription drugs |
| title_auth | Profits before people? ethical standards and the marketing of prescription drugs |
| title_exact_search | Profits before people? ethical standards and the marketing of prescription drugs |
| title_full | Profits before people? ethical standards and the marketing of prescription drugs Leonard J. Weber |
| title_fullStr | Profits before people? ethical standards and the marketing of prescription drugs Leonard J. Weber |
| title_full_unstemmed | Profits before people? ethical standards and the marketing of prescription drugs Leonard J. Weber |
| title_short | Profits before people? |
| title_sort | profits before people ethical standards and the marketing of prescription drugs |
| title_sub | ethical standards and the marketing of prescription drugs |
| topic | Ethik Pharmaceutical industry Moral and ethical aspects United States Marketing Moral and ethical aspects United States Wirtschaftsethik (DE-588)4066439-9 gnd Ethik (DE-588)4015602-3 gnd Unternehmensethik (DE-588)4202404-3 gnd Pharmazeutische Industrie (DE-588)4045696-1 gnd Arzneimittelmarkt (DE-588)4003131-7 gnd Vermarktung (DE-588)4121857-7 gnd Arzneimittel (DE-588)4003115-9 gnd Arzneimittelsicherheit (DE-588)4143182-0 gnd |
| topic_facet | Ethik Pharmaceutical industry Moral and ethical aspects United States Marketing Moral and ethical aspects United States Wirtschaftsethik Unternehmensethik Pharmazeutische Industrie Arzneimittelmarkt Vermarktung Arzneimittel Arzneimittelsicherheit USA |
| work_keys_str_mv | AT weberleonardj profitsbeforepeopleethicalstandardsandthemarketingofprescriptiondrugs |